Versant Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$307K Sell
757
-252
-25% -$102K 0.05% 313
2025
Q1
$502K Buy
1,009
+511
+103% +$254K 0.08% 155
2024
Q4
$259K Sell
498
-2
-0.4% -$1.04K 0.06% 149
2024
Q3
$309K Buy
500
+66
+15% +$40.8K 0.07% 118
2024
Q2
$240K Buy
434
+202
+87% +$112K 0.06% 126
2024
Q1
$135K Hold
232
0.04% 157
2023
Q4
$123K Sell
232
-4
-2% -$2.12K 0.04% 163
2023
Q3
$119K Buy
236
+9
+4% +$4.56K 0.04% 158
2023
Q2
$118K Sell
227
-16
-7% -$8.35K 0.04% 167
2023
Q1
$140K Sell
243
-9
-4% -$5.18K 0.05% 145
2022
Q4
$139K Sell
252
-349
-58% -$192K 0.05% 131
2022
Q3
$305K Buy
601
+1
+0.2% +$507 0.12% 79
2022
Q2
$326K Buy
600
+4
+0.7% +$2.17K 0.12% 80
2022
Q1
$352K Sell
596
-162
-21% -$95.7K 0.11% 81
2021
Q4
$506K Hold
758
0.17% 67
2021
Q3
$433K Buy
758
+8
+1% +$4.57K 0.15% 68
2021
Q2
$378K Buy
750
+16
+2% +$8.06K 0.14% 71
2021
Q1
$335K Buy
734
+44
+6% +$20.1K 0.12% 80
2020
Q4
$321K Hold
690
0.13% 73
2020
Q3
$304K Hold
690
0.14% 74
2020
Q2
$250K Hold
690
0.11% 80
2020
Q1
$195K Sell
690
-25
-3% -$7.07K 0.1% 85
2019
Q4
$232K Sell
715
-12
-2% -$3.89K 0.12% 74
2019
Q3
$211K Sell
727
-16
-2% -$4.64K 0.1% 83
2019
Q2
$218K Sell
743
-99
-12% -$29K 0.1% 83
2019
Q1
$230K Sell
842
-19
-2% -$5.19K 0.1% 85
2018
Q4
$192K Hold
861
0.09% 92
2018
Q3
$210K Sell
861
-2
-0.2% -$488 0.09% 90
2018
Q2
$178K Sell
863
-13
-1% -$2.68K 0.08% 102
2018
Q1
$180K Sell
876
-18
-2% -$3.7K 0.07% 107
2017
Q4
$169K Sell
894
-9
-1% -$1.7K 0.07% 112
2017
Q3
$170K Hold
903
0.09% 87
2017
Q2
$157K Hold
903
0.09% 89
2017
Q1
$138K Hold
903
0.08% 101
2016
Q4
$127K Sell
903
-16
-2% -$2.25K 0.07% 102
2016
Q3
$146K Sell
919
-1
-0.1% -$159 0.08% 97
2016
Q2
$135K Hold
920
0.08% 99
2016
Q1
$130K Buy
920
+5
+0.5% +$707 0.08% 98
2015
Q4
$129K Buy
+915
New +$129K 0.08% 98